Skip to main content
logo
Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
496.07
+12.04 (2.49%)
At close: Aug 7, 2026, 4:00 PM EDT
495.32
-0.75 (-0.15%)
After-hours: Aug 7, 2026, 7:58 PM EDT

BNT Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
12,58712,00111,0209,8698,9317,574
Revenue Growth
10.23%8.90%11.66%10.51%17.91%22.06%
Gross Profit
10,82410,3509,4908,6077,8506,670
Operating Income
4,7774,173-232.93,8324,3072,782
Net Income
4,4053,953-535.63,6203,3222,342
Earnings Per Share
17.1815.32-2.0813.8912.829.01
EPS Growth
22.80%--8.35%42.29%-12.44%

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Trikafta / Kaftrio
10,07810,31310,2398,9457,6875,697
Alyftrek
1,625837.8----
Casgevy
190.5115.810---
Journavx
124.959.6----
Other Collaborative and Royalty
-30.7---1
Revenue (Total)
12,58712,00111,0209,8698,9317,574

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
7,8526,6086,11611,21810,7797,525
Total Debt
1,9781,8471,544724.7810.3887.2
Net Cash (Debt)
5,8754,7624,57210,4949,9686,638
Net Cash Growth
21.00%4.16%-56.44%5.27%50.18%15.05%
Net Cash Per Share
22.9218.4617.7340.2838.4725.54

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
4,2933,631-492.63,5374,1302,644
Capital Expenditures
-496.8-437.6-297.7-200.4-204.7-235
Free Cash Flow
3,7963,194-790.33,3373,9252,409
Free Cash Flow Growth
8.47%---14.99%62.97%-19.55%

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
86.00%86.24%86.11%87.21%87.90%88.06%
Operating Margin
37.95%34.77%-2.11%38.83%48.23%36.73%
Pretax Margin
41.90%38.69%2.25%44.38%47.39%36.05%
Profit Margin
35.00%32.94%-4.86%36.68%37.20%30.92%
FCF Margin
30.16%26.61%-7.17%33.81%43.95%31.80%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
28.8729.59-29.2922.5324.37
Forward PE
25.0122.6122.6624.4418.8316.42
P/FCF Ratio
33.1236.05-31.4218.9123.20
PS Ratio
9.999.599.3910.628.317.38